The recent FDA approval of topical JAK inhibitors for children 2 years or older marks a significant advancement in pediatric ...

Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...

Roflumilast 0.05% cream, a phosphodiesterase 4 inhibitor, was approved by the FDA on October 6, having been specifically ...

Curious if alcohol can worsen your eczema? Learn whether drinking could affect your condition and interact with any ...

Evommune, Inc. targets a $100M IPO to fund inflammation therapies. Click for more about EVMN stock, its drug pipeline, market ...

First OX40 Targeted Therapy Approval By 2030 Says Kuick Research In New Research StudyDelhi, Oct. 14, 2025 (GLOBE NEWSWIRE) - ...

Shaperon secures phase 2 trials for atopic dermatitis treatment Nugel after positive review Shaperon, a domestic bio corporation, has confirmed the safety and efficacy of its atopic dermatitis ...

Sitryx Therapeutics (“the Company”), a clinical-stage biopharmaceutical company developing novel oral therapies to restore ...

This Mendelian randomization study found that low-calorie diets may slightly increase the risk of psoriatic arthritis, while ...

A new study published in the journal of Cureus revealed that the effects of smoking stretch beyond the lungs and heart, and ...

For me, there are two main takeaways from the study. The first is that we still don't take CSU seriously enough. It is a ...